Health Catalyst Stock Buy Hold or Sell Recommendation
| HCAT Stock | USD 4.14 0.03 0.73% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Health Catalyst is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Health Catalyst given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Health Catalyst, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Health Catalyst Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Health Stock please use our How to Invest in Health Catalyst guide. Note, we conduct extensive research on individual companies such as Health and provide practical buy, sell, or hold advice based on investors' constraints. Health Catalyst. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Health |
Execute Health Catalyst Buy or Sell Advice
The Health recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Health Catalyst. Macroaxis does not own or have any residual interests in Health Catalyst or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Health Catalyst's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Health Catalyst Trading Alerts and Improvement Suggestions
| Health Catalyst generated a negative expected return over the last 90 days | |
| Health Catalyst has high historical volatility and very poor performance | |
| Health Catalyst has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 306.58 M. Net Loss for the year was (69.5 M) with profit before overhead, payroll, taxes, and interest of 141.79 M. | |
| Over 77.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Daniel Lesueur Sells 16,902 Shares of Health Catalyst, Inc. Stock |
Health Catalyst Returns Distribution Density
The distribution of Health Catalyst's historical returns is an attempt to chart the uncertainty of Health Catalyst's future price movements. The chart of the probability distribution of Health Catalyst daily returns describes the distribution of returns around its average expected value. We use Health Catalyst price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Health Catalyst returns is essential to provide solid investment advice for Health Catalyst.
| Mean Return | -0.99 | Value At Risk | -7.22 | Potential Upside | 5.04 | Standard Deviation | 3.64 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Health Catalyst historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Health Stock Institutional Investors
The Health Catalyst's institutional investors refer to entities that pool money to purchase Health Catalyst's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Geode Capital Management, Llc | 2024-12-31 | 1.4 M | Bank Of New York Mellon Corp | 2024-12-31 | 1.4 M | Jpmorgan Chase & Co | 2024-12-31 | 1.2 M | State Street Corp | 2024-12-31 | 1.2 M | Goldman Sachs Group Inc | 2024-12-31 | 886.7 K | Portolan Capital Management, Llc | 2024-12-31 | 749 K | American Century Companies Inc | 2024-12-31 | 710.5 K | Nuveen Asset Management, Llc | 2024-12-31 | 593.6 K | Northern Trust Corp | 2024-12-31 | 526.6 K | Blackrock Inc | 2024-12-31 | 5.6 M | First Light Asset Management, Llc | 2024-12-31 | 5.2 M |
Health Catalyst Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 2.5M | (3.7M) | (7.1M) | (8.3M) | (7.5M) | (7.1M) | |
| Investments | 29.5M | (74.5M) | (39.0M) | (3.4M) | (22.9M) | (24.0M) | |
| Change In Cash | 73.9M | 101.3M | (76.9M) | (10.0M) | 143.4M | 150.5M | |
| Free Cash Flow | (36.6M) | (41.6M) | (52.7M) | (47.4M) | 12.9M | 13.6M | |
| Depreciation | 18.7M | 37.5M | 48.3M | 42.2M | 41.4M | 29.0M | |
| Other Non Cash Items | 37.3M | 29.9M | 162K | 750K | 3.1M | 2.9M | |
| Capital Expenditures | 10.5M | 18.5M | 17.4M | 14.3M | 1.6M | 1.5M | |
| Net Income | (115.0M) | (153.2M) | (137.4M) | (118.1M) | (69.5M) | (73.0M) | |
| End Period Cash Flow | 92.0M | 193.2M | 116.3M | 106.3M | 249.6M | 262.1M | |
| Change To Netincome | 22.3M | 60.1M | 76.0M | 66.2M | 76.2M | 43.3M |
Health Catalyst Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Health Catalyst or Health Care Technology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Health Catalyst's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Health stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.88 | |
β | Beta against Dow Jones | 1.12 | |
σ | Overall volatility | 3.76 | |
Ir | Information ratio | -0.24 |
Health Catalyst Volatility Alert
Health Catalyst exhibits very low volatility with skewness of -0.26 and kurtosis of 0.17. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Health Catalyst's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Health Catalyst's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Health Catalyst Fundamentals Vs Peers
Comparing Health Catalyst's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Health Catalyst's direct or indirect competition across all of the common fundamentals between Health Catalyst and the related equities. This way, we can detect undervalued stocks with similar characteristics as Health Catalyst or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Health Catalyst's fundamental indicators could also be used in its relative valuation, which is a method of valuing Health Catalyst by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Health Catalyst to competition |
| Fundamentals | Health Catalyst | Peer Average |
| Return On Equity | -0.19 | -0.31 |
| Return On Asset | -0.0457 | -0.14 |
| Profit Margin | (0.23) % | (1.27) % |
| Operating Margin | (0.19) % | (5.51) % |
| Current Valuation | 298.83 M | 16.62 B |
| Shares Outstanding | 70.21 M | 571.82 M |
| Shares Owned By Insiders | 3.50 % | 10.09 % |
| Shares Owned By Institutions | 76.61 % | 39.21 % |
| Number Of Shares Shorted | 2.06 M | 4.71 M |
| Price To Earning | (2.62) X | 28.72 X |
| Price To Book | 0.79 X | 9.51 X |
| Price To Sales | 0.95 X | 11.42 X |
| Revenue | 306.58 M | 9.43 B |
| Gross Profit | 141.79 M | 27.38 B |
| EBITDA | (27.1 M) | 3.9 B |
| Net Income | (69.5 M) | 570.98 M |
| Cash And Equivalents | 403.35 M | 2.7 B |
| Cash Per Share | 7.37 X | 5.01 X |
| Total Debt | 251.09 M | 5.32 B |
| Debt To Equity | 0.53 % | 48.70 % |
| Current Ratio | 5.15 X | 2.16 X |
| Book Value Per Share | 5.70 X | 1.93 K |
| Cash Flow From Operations | 14.56 M | 971.22 M |
| Short Ratio | 2.82 X | 4.00 X |
| Earnings Per Share | (1.15) X | 3.12 X |
| Target Price | 8.42 | |
| Number Of Employees | 1.5 K | 18.84 K |
| Beta | 1.41 | -0.15 |
| Market Capitalization | 290.67 M | 19.03 B |
| Total Asset | 858.93 M | 29.47 B |
| Retained Earnings | (1.19 B) | 9.33 B |
| Working Capital | 139.8 M | 1.48 B |
| Current Asset | 216.75 M | 9.34 B |
Note: Disposition of 13827 shares by Benjamin Landry of Health Catalyst at 4.5462 subject to Rule 16b-3 [view details]
Health Catalyst Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Health . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Health Catalyst Buy or Sell Advice
When is the right time to buy or sell Health Catalyst? Buying financial instruments such as Health Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Health Catalyst in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Basic Utilities Thematic Idea Now
Basic Utilities
Companies involved in production and distribution of electric, gas, water, and other energy utilities. The Basic Utilities theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Basic Utilities Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Health Stock Analysis
When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.